FDA Accepts Orexo’s Resubmitted IZIPRY Application for Review
Orexo said the FDA accepted its resubmitted registration application for IZIPRY for review.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Orexo said the FDA accepted its resubmitted registration application for IZIPRY for review.